IT
Indaptus Therapeutics Inc
🇺🇸XNAS.INDPUnited StatesHealthcare
$1.22USDup +0.14 (+12.96%)OpenEnd of day5:41 PM
Price$1.22+0.14 (+12.96%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US45339J2042
- CUSIP
- 45339J105
Company
- Employees
- 5
- Headquarters
- New York, United States
- Website
- https://indaptusrx.com
- CEO
- Mr. Junyi Dai
Market
- Shares outstanding
- 133.2M
- Market cap
- $2.74M
Highlights
- Market cap
- $2.74M
- EPS LTM
- -$0.13
- P/E LTM
- -9.19calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$15.42M+9.07%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$15.18M-1.39%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.